Batanopride (BMY-25801) is an antiemetic drug of the benzamide class which acts as a selective 5-HT3 receptor antagonist. It was trialled to reduce nausea during cancer chemotherapy but was never approved for medical use due to dose-limiting side effects including hypotension and long QT syndrome.
This page contains content from the copyrighted Wikipedia article "Batanopride"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
